GlassScriptPhysician profile
Vinoo Kishan Ramsaran
NPI 1649409764
$9,258.42
in general payments reported to CMS, 2019-2025
49 companies · $1,915 in 2025
The $1,915 reported for 2025 was more than what 75% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $511 · 2020: $326 · 2021: $649 · 2022: $1,025 · 2023: $2,740 · 2024: $2,091 · 2025: $1,915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,647 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,646.62 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,407.98 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $996.26 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $767.54 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Genzyme Corporation | $574.85 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $511.29 | 2019-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $471.32 | 2022-2025 | Zerbaxa, Recarbrio, Dificid |
| Mylan Specialty L.P. | $436.57 | 2019-2024 | Yupelri |
| United Therapeutics Corporation | $363.21 | 2021-2025 | Tyvaso, Orenitram, Remodulin |
| Jazz Pharmaceuticals INC. | $328.25 | 2022-2025 | |
| Insmed, INC. | $325.43 | 2020-2024 | Arikayce |
| Actelion Pharmaceuticals US, INC. | $292.00 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| Inogen, INC. | $241.47 | 2022-2025 | Inogen |
| Mallinckrodt Hospital Products INC. | $241.00 | 2021-2025 | Acthar |
| Ani Pharmaceuticals, INC. | $231.34 | 2023-2025 | Purified Cortrophin Gel |
| Electromed, INC. | $225.13 | 2019-2025 | Smartvest |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $187.91 | 2022-2025 | Tezspire |
| Shionogi INC | $155.36 | 2023-2025 | Fetroja |
| Philips North America LLC | $143.02 | 2019-2025 | Vest Therapy Und |
| Viatris Specialty LLC | $124.69 | 2025 | Yupelri |
| Harmony Biosciences LLC | $122.74 | 2022-2025 | |
| Inspire Medical Systems, INC. | $100.94 | 2025 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $95.04 | 2023-2025 | Glassia, Cuvitru |
| La Jolla Pharmaceutical Company | $91.12 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $89.30 | 2024-2025 | Lumryz |
| Grifols USA, LLC | $72.51 | 2022-2024 | Prolastin-C Liquid |
| Axsome Therapeutics, INC. | $70.47 | 2023-2024 | Sunosi |
| Abbvie INC. | $62.64 | 2022-2024 | |
| Genentech USA, INC. | $59.37 | 2019-2022 | |
| Baxter Healthcare | $54.71 | 2022-2023 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Novartis Pharmaceuticals Corporation | $46.14 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.55 | 2019 | |
| Circassia INC. | $34.38 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $27.05 | 2023 | Quviviq |
| Pulmonx Corporation | $25.54 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Gilead Sciences, INC. | $21.53 | 2022 | |
| Fisher & Paykel Healthcare INC | $21.42 | 2025 | Fisher & Paykel Healthcare |
| Phadia US INC. | $19.91 | 2024 | Immunocap |
| Lilly USA, LLC | $18.00 | 2025 | Zepbound |
| Verona Pharma, INC. | $17.96 | 2025 | Ohtuvayre |
| Scpharmaceuticals INC. | $17.95 | 2025 | |
| Itamar Medical INC | $17.39 | 2023 | Watchpatone |
| Paratek Pharmaceuticals, INC. | $15.88 | 2020 | |
| Medtronic, INC. | $15.09 | 2023 | Illumisite |
| Ambu INC. | $15.08 | 2022 | |
| Chiesi USA, INC. | $13.78 | 2020 | |
| Pfizer INC. | $12.98 | 2022 | |
| Sunovion Pharmaceuticals INC. | $12.01 | 2019 | |
| Advanced Respiratory, INC | $11.94 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $11.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinoo Ramsaran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.